# NKX3-1

## Overview
NKX3-1 is a gene that encodes the NK3 homeobox 1 protein, a transcription factor primarily involved in the development and maintenance of prostate tissue. The NK3 homeobox 1 protein is characterized by its homeodomain, a helix-turn-helix motif that facilitates DNA binding, allowing it to regulate gene expression critical for prostate epithelial cell differentiation and function (Zheng2006GermLine; Padmanabhan2016Regulating). As a transcription factor, NK3 homeobox 1 plays a dual role, acting as both a transcriptional repressor and activator depending on the cellular context (Shen2003Roles). The gene's expression is androgen-regulated, underscoring its importance in prostatic growth and differentiation (Shen2003Roles). Clinically, NKX3-1 is recognized as a tumor suppressor, with its loss or reduced expression being a common early event in prostate cancer development, highlighting its potential as a biomarker and therapeutic target in oncology (Asatiani2005Deletion; Zhang2008Loss).

## Structure
The NKX3-1 protein is a transcription factor with a primary structure consisting of 234 amino acids. It is divided into three main regions: the N-terminal region (amino acids 1-123), the homeodomain (amino acids 124-183), and the C-terminal tail (amino acids 184-234) (Padmanabhan2016Regulating). The homeodomain is a 60 amino acid helix-turn-helix motif crucial for DNA binding and contains a nuclear localization signal (Zheng2006GermLine; Padmanabhan2016Regulating). 

The tertiary structure of NKX3-1 involves specific interactions within the homeodomain, such as hydrogen bonds between Thr 164 and Gln 167, which are part of the N-capping motif initiating the third helix (Zheng2006GermLine). The C-terminal tail includes a 21 amino acid sequence that functions as a degron for ubiquitin-independent turnover through the 26S proteasome, with a conserved proline at position 221 being critical for this process (Padmanabhan2016Regulating).

Post-translational modifications, such as phosphorylation, play a significant role in regulating NKX3-1's stability and function. The N-terminal region contains a PEST sequence phosphorylated by protein kinases CK2 and PIM1, protecting NKX3-1 from degradation (Padmanabhan2016Regulating). The acidic domain (AD) and SRF interacting (SI) motifs in the N-terminal region also interact with the homeodomain, affecting its stability and DNA binding (Ju2009Interactions).

## Function
The NKX3-1 gene encodes a homeobox protein that plays a crucial role in prostate development and maintenance. It is primarily expressed in the prostate, where it is involved in the differentiation and maintenance of prostate epithelial cells. NKX3-1 functions as a transcription factor, binding to specific DNA sequences to regulate gene expression. This regulation is essential for maintaining the integrity of prostate epithelial cells and ensuring normal secretory function (Shen2003Roles; ORNSTEIN2001EXPRESSION).

NKX3-1 is androgen-regulated, meaning its expression is dependent on androgen signaling, which is critical for prostatic growth and differentiation. The protein is localized in the nuclei of luminal epithelial cells in the prostate, where it contributes to the production of prostatic secretory proteins (Shen2003Roles). In healthy human cells, NKX3-1 acts as a transcriptional repressor by recruiting Groucho/TLE corepressors, although it can also function as a transcriptional activator in certain contexts (Shen2003Roles).

The gene's expression is restricted to prostatic tissue in adults, highlighting its role in maintaining prostate-specific cellular functions and differentiation. Loss of NKX3-1 expression is associated with the progression of prostate cancer, indicating its potential role in preventing neoplastic changes (Shen2003Roles; He1997A).

## Clinical Significance
The NKX3-1 gene is clinically significant due to its role as a tumor suppressor in prostate cancer. Alterations in NKX3-1 expression, such as deletions and reduced expression levels, are frequently observed in prostate cancer, particularly in early stages of the disease. Approximately 63% of prostate cancer samples show deletion of the NKX3-1 gene, which correlates with decreased expression of the NKX3-1 protein and is considered an early event in prostate carcinogenesis (Asatiani2005Deletion). The loss of NKX3-1 function is associated with defects in prostatic protein secretion and ductal morphogenesis, contributing to the progression of prostate cancer (Zhang2008Loss).

NKX3-1 is also implicated in the development of prostatic intraepithelial neoplasia (PIN), a precursor to prostate cancer, as its loss leads to epithelial hyperplasia and dysplasia in mouse models (Abdulkadir2002Conditional). The gene's deletion or reduced expression is linked to advanced-stage prostate cancer, including hormone-refractory and metastatic forms, where it may facilitate the expression of vascular endothelial growth factor-C (VEGF-C), promoting metastasis (Zhang2008Loss).

Additionally, the loss of NKX3-1 may interact with the TMPRSS2-ERG fusion gene, a common alteration in prostate cancer, potentially enhancing oncogenic activity (Thangapazham2014Loss).

## Interactions
NKX3-1, a prostate tumor suppressor protein, engages in several significant interactions with other proteins and nucleic acids. It interacts with topoisomerase I, a DNA-resolving enzyme, enhancing ATM kinase activation and co-localizing in the nucleus following DNA damage. This interaction is crucial for the DNA damage response and affects the sensitivity of cells to camptothecin, a chemotherapeutic agent targeting topoisomerase I (Song2013Structural). NKX3-1 also binds to the serum response factor (SRF), with interactions occurring at two separate domains within NKX3-1, one amino-terminal and another carboxy-terminal to the homeodomain. These interactions are important for transcriptional regulation (Zhang2008Structural).

NKX3-1 interacts with Sp-family proteins, negatively regulating their transcriptional activity in prostate-derived cells. It forms specific complexes with Sp proteins, particularly Sp2 and Sp5, through its homeodomain and N-terminal regions. These interactions do not disrupt the DNA-binding capabilities of Sp proteins but involve mechanisms that may include attracting co-repressors or interfering with co-activators (Simmons2005Nkx3.1). Additionally, NKX3-1 is regulated by protein kinase CK2, which phosphorylates it at specific sites, affecting its stability and degradation (Li2006NKX3.1).


## References


[1. (Abdulkadir2002Conditional) Sarki A. Abdulkadir, Jeffrey A. Magee, Thomas J. Peters, Zahid Kaleem, Cathy K. Naughton, Peter A. Humphrey, and Jeffrey Milbrandt. Conditional loss of nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Molecular and Cellular Biology, 22(5):1495–1503, March 2002. URL: http://dx.doi.org/10.1128/mcb.22.5.1495-1503.2002, doi:10.1128/mcb.22.5.1495-1503.2002. This article has 191 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.22.5.1495-1503.2002)

[2. (Song2013Structural) Liang-Nian Song, Cai Bowen, and Edward P. Gelmann. Structural and functional interactions of the prostate cancer suppressor protein nkx3.1 with topoisomerase i. Biochemical Journal, 453(1):125–136, June 2013. URL: http://dx.doi.org/10.1042/BJ20130012, doi:10.1042/bj20130012. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/BJ20130012)

[3. (He1997A) Wei Wu He, Peter J. Sciavolino, John Wing, Meena Augustus, Peter Hudson, P.Scott Meissner, R.Thomas Curtis, Brenda K. Shell, David G. Bostwick, Donald J. Tindall, Edward P. Gelmann, Cory Abate-Shen, and Kenneth C. Carter. A novel human prostate-specific, androgen-regulated homeobox gene (nkx3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics, 43(1):69–77, July 1997. URL: http://dx.doi.org/10.1006/GENO.1997.4715, doi:10.1006/geno.1997.4715. This article has 506 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/GENO.1997.4715)

[4. (Simmons2005Nkx3.1) Steven O. Simmons and Jonathan M. Horowitz. Nkx3.1 binds and negatively regulates the transcriptional activity of sp-family members in prostate-derived cells. Biochemical Journal, 393(1):397–409, December 2005. URL: http://dx.doi.org/10.1042/bj20051030, doi:10.1042/bj20051030. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20051030)

[5. (Ju2009Interactions) Jeong Ho Ju, Jin-Soo Maeng, Duck-Yeon Lee, Grzegorz Piszczek, Edward P. Gelmann, and James M. Gruschus. Interactions of the acidic domain and srf interacting motifs with the nkx3.1 homeodomain. Biochemistry, 48(44):10601–10607, October 2009. URL: http://dx.doi.org/10.1021/bi9013374, doi:10.1021/bi9013374. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi9013374)

[6. (Zhang2008Loss) Heyu Zhang, Michael H. Muders, Jinping Li, Francesca Rinaldo, Donald J. Tindall, and Kaustubh Datta. Loss of nkx3.1 favors vascular endothelial growth factor-c expression in prostate cancer. Cancer Research, 68(21):8770–8778, October 2008. URL: http://dx.doi.org/10.1158/0008-5472.can-08-1912, doi:10.1158/0008-5472.can-08-1912. This article has 26 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-08-1912)

[7. (ORNSTEIN2001EXPRESSION) DAVID K. ORNSTEIN, MARIO CINQUANTA, SOLLY WEILER, PAUL H. DURAY, MICHAEL R. EMMERT-BUCK, CATHY D. VOCKE, W. MARSTON LINEHAN, and JAMES A. FERRETTI. Expression studies and mutational analysis of the androgen regulated homeobox gene nkx3.1 in benign and malignant prostate epithelium. Journal of Urology, 165(4):1329–1334, April 2001. URL: http://dx.doi.org/10.1016/S0022-5347(01)69894-X, doi:10.1016/s0022-5347(01)69894-x. This article has 116 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/S0022-5347(01)69894-X)

[8. (Li2006NKX3.1) Xiang Li, Bin Guan, Sam Maghami, and Charles J. Bieberich. Nkx3.1 is regulated by protein kinase ck2 in prostate tumor cells. Molecular and Cellular Biology, 26(8):3008–3017, April 2006. URL: http://dx.doi.org/10.1128/mcb.26.8.3008-3017.2006, doi:10.1128/mcb.26.8.3008-3017.2006. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.26.8.3008-3017.2006)

[9. (Zhang2008Structural) Yan Zhang, Rebecca A. Fillmore, and Warren E. Zimmer. Structural and functional analysis of domains mediating interaction between the bagpipe homologue, nkx3.1 and serum response factor. Experimental Biology and Medicine, 233(3):297–309, March 2008. URL: http://dx.doi.org/10.3181/0709-rm-236, doi:10.3181/0709-rm-236. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3181/0709-rm-236)

[10. (Shen2003Roles) Michael M. Shen and Cory Abate‐Shen. Roles of the nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Developmental Dynamics, 228(4):767–778, November 2003. URL: http://dx.doi.org/10.1002/dvdy.10397, doi:10.1002/dvdy.10397. This article has 77 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dvdy.10397)

[11. (Thangapazham2014Loss) Rajesh Thangapazham, Francisco Saenz, Shilpa Katta, Ahmed A Mohamed, Shyh-Han Tan, Gyorgy Petrovics, Shiv Srivastava, and Albert Dobi. Loss of the nkx3.1 tumorsuppressor promotes the tmprss2-erg fusion gene expression in prostate cancer. BMC Cancer, January 2014. URL: http://dx.doi.org/10.1186/1471-2407-14-16, doi:10.1186/1471-2407-14-16. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2407-14-16)

[12. (Padmanabhan2016Regulating) Achuth Padmanabhan, Varsha Rao, Angelo M. De Marzo, and Charles J. Bieberich. Regulating nkx3.1 stability and function: post-translational modifications and structural determinants: post-translational regulation of tumor suppressor nkx3.1. The Prostate, 76(6):523–533, February 2016. URL: http://dx.doi.org/10.1002/pros.23144, doi:10.1002/pros.23144. This article has 19 citations.](https://doi.org/10.1002/pros.23144)

[13. (Asatiani2005Deletion) Ekatherine Asatiani, Wen-Xin Huang, Antai Wang, Elizabeth Rodriguez Ortner, Luciane R. Cavalli, Bassem R. Haddad, and Edward P. Gelmann. Deletion, methylation, and expression of the nkx3.1 suppressor gene in primary human prostate cancer. Cancer Research, 65(4):1164–1173, February 2005. URL: http://dx.doi.org/10.1158/0008-5472.can-04-2688, doi:10.1158/0008-5472.can-04-2688. This article has 127 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-04-2688)

[14. (Zheng2006GermLine) S. Lilly Zheng, Jeong-ho Ju, Bao-li Chang, Elizabeth Ortner, Jielin Sun, Sarah D. Isaacs, Jishang Sun, Kathy E. Wiley, Wennuan Liu, Micheas Zemedkun, Patrick C. Walsh, James Ferretti, James Gruschus, William B. Isaacs, Edward P. Gelmann, and Jianfeng Xu. Germ-line mutation of nkx3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Cancer Research, 66(1):69–77, January 2006. URL: http://dx.doi.org/10.1158/0008-5472.can-05-1550, doi:10.1158/0008-5472.can-05-1550. This article has 40 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-05-1550)